IP Library Granted Patent US 7,214,242
Granted Patent B2
US 7,214,242 · App. 10/378,178 · Granted May 8, 2007

Bioengineered tubular graft prostheses

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,214,242
App. No.
10/378,178
Granted
May 8, 2007
Kind
B2
Abstract

The invention is directed to bioengineered tubular graft prostheses prepared from cleaned tissue material derived from animal sources. The bioengineered graft prostheses of the invention are prepared using methods that preserve cell compatibility, strength, and bioremodelability of the processed tissue matrix. The bioengineered graft prostheses are used for implantation, repair, or for use in a mammalian host.

Claims (10)

1. A method for producing a bioremodelable prosthetic tube construct comprising at least two layers of processed tissue matrix wherein the method comprises:

(a) flagging the processed tissue matrix around a sleeve-covered mandrel by hydrating one edge of the processed tissue matrix and contacting the sleeve-covered mandrel by hydrating one edge of the processed tissue matrix and contacting the sleeve-covered mandrel to the hydrated edge of the processed tissue matrix;

(b) drying the processed tissue matrix to the sleeve-covered mandrel;

(c) rehydrating the processed tissue matrix with a hydrating agent to form hydrated tissue matrix;

(d) rotating the mandrel at least twice to wrap the hydrated processed tissue matrix to form at least two wrapped hydrated layers of processed tissue matrix;

(e) dehydrating the layers of the processed tissue matrix; and

(f) contacting the layers of the processed tissue matrix with a crosslink agent to crosslink the collagen.

2. The method of claim 1 , wherein the processed tissue matrix comprises less than about 5% dry weight glycoproteins, glycosaminoglycans, proteoglycans, lipids, non-collagenous proteins and nucleic acids.

3. The method of claim 1 , wherein the processed tissue matrix comprises about 93% by dry weight acellular telopeptide collagen.

4. The method of claim 1 , wherein the processed tissue matrix is substantially free of cells and cellular debris.

Assignments (4)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT Recorded Aug 6, 2021
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 057112/0677 →
SECURITY INTEREST Recorded Jun 19, 2018
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 046392/0242 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ORGANOGENESIS INC.
Reel/Frame 042072/0977 →
SECURITY AGREEMENT Recorded Sep 23, 2011
From: ORGANOGENESIS, INC.
To: WELLS FARGO BANK, N.A.
Reel/Frame 026954/0666 →